Research Trial:
Researchers at Monash Medical Centre, Clayton in collaboration with the World Health Organisation are trialing a new male contraceptive method. We need healthy couples living in a stable relationship and not planning pregnancy for two years.
more details >>

Harrison CA , Gray PC, Vale WW, Robertson DM. Antagonists of activin signaling: mechanisms and potential biological applications. Trends Endocrinol Metab. 2005 Mar;16(2):73-8.

Robertson DM, Pruysers E, Burger HG, Jobling T, McNeilage J, Healy D.Inhibins and ovarian cancer. Mol Cell Endocrinol. 2004 Oct 15;225(1-2):65-71.

Harrison CA, Wiater E, Gray PC, Greenwald J, Choe S, Vale W. Modulation of activin and BMP signaling. Mol Cell Endocrinol. 2004 Oct 15;225(1-2):19-24.

Robertson DM, McNeilage J. Inhibins as biomarkers for reproductive cancers. Semin Reprod Med. 2004 Aug;22(3):219-25.

Harrison CA, Gray PC, Fischer W, Donaldson C, Choe S, Vale W. An activin mutant with disrupted ALK4 binding blocks signaling via type II receptors. J Biol Chem. 2004 Jul 2;279(27):28036-44.

Landgren BM, Collins A, Csemiczky G, Burger HG, Baksheev L, Robertson DM. Menopause transition: Annual changes in serum hormonal patterns over the menstrual cycle in women during a nine-year period prior to menopause. J Clin Endocrinol Metab. 2004 Jun;89(6):2763-9.

Robertson DM, Burger HG, Fuller PJ. Inhibin/activin and ovarian cancer. Endocr Relat Cancer. 2004 Mar;11(1):35-49.

McLachlan RI, Robertson DM, Pruysers E, Ugoni A, Matsumoto AM, Anawalt BD, Bremner WJ, Meriggiola C. Relationship between serum gonadotropins and spermatogenic suppression in men undergoing steroidal contraceptive treatment. J Clin Endocrinol Metab. 2004 Jan;89(1):142-9.

Robertson DM, Stephenson T, McLachlan RI. Characterization of plasma inhibin forms in fertile and infertile men. Hum Reprod. 2003 May;18(5):1047-54.

Matthiesson KL, Robertson DM, Burger HG, McLachlan RI. Response of serum inhibin B and pro-alphaC levels to gonadotrophic stimulation in normal men before and after steroidal contraceptive treatment. Hum Reprod. 2003 Apr;18(4):734-43.

Thirunavukarasu P, Robertson DM, Dole A, Waldron K, Dawson G, Wallace EM. Placental, maternal serum and amniotic fluid molecular weight forms of inhibin A and pro-alphaC. Placenta. 2003 Apr;24(4):370-7.

Pratis K, O'Donnell L, Ooi GT, Stanton PG, McLachlan RI, Robertson DM. Differential regulation of rat testicular 5alpha-reductase type 1 and 2 isoforms by testosterone and FSH. J Endocrinol. 2003 Mar;176(3):393-403.

Gilfillan CP, Montgomery GW, Zhu G, Martin NG, Groome NP, Robertson DM. Serum inhibin A and B concentrations during the menstrual cycle in mothers of spontaneous dizygotic twins. Twin Res. 2003 Feb;6(1):27-33.

Killian J, Pratis K, Clifton RJ, Stanton PG, Robertson DM, O'Donnell L. 5alpha-reductase isoenzymes 1 and 2 in the rat testis during postnatal development. Biol Reprod. 2003 May;68(5):1711-8.

Parker KI, Robertson DM, Groome NP, Macmillan KL. Plasma concentrations of inhibin a and follicle-stimulating hormone differ between cows with two or three waves of ovarian follicular development in a single estrous cycle. Biol Reprod. 2003 Mar;68(3):822-8.




© Prince Henry's Institute of Medical Research Disclaimer | Links to other sites
ABN 77 601 754 678